|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Net sales (Notes 2 and 11) | $ 22,070us-gaap_SalesRevenueNet | $ 25,032us-gaap_SalesRevenueNet | $ 22,406us-gaap_SalesRevenueNet |
| Cost of sales (Note 2) | 7,891us-gaap_CostOfGoodsAndServicesSold | 8,361us-gaap_CostOfGoodsAndServicesSold | 8,154us-gaap_CostOfGoodsAndServicesSold |
| Gross profit | 14,179us-gaap_GrossProfit | 16,671us-gaap_GrossProfit | 14,252us-gaap_GrossProfit |
| Operating expenses: | |||
| Sales and marketing | 8,965us-gaap_SellingAndMarketingExpense | 9,538us-gaap_SellingAndMarketingExpense | 8,946us-gaap_SellingAndMarketingExpense |
| Administrative | 8,143us-gaap_GeneralAndAdministrativeExpense | 5,893us-gaap_GeneralAndAdministrativeExpense | 6,127us-gaap_GeneralAndAdministrativeExpense |
| Research and development (Note 2) | 1,322us-gaap_ResearchAndDevelopmentExpense | 824us-gaap_ResearchAndDevelopmentExpense | 1,301us-gaap_ResearchAndDevelopmentExpense |
| Settlement benefit (Note 5) | 0prph_SettlementBenefit | 0prph_SettlementBenefit | (1,024)prph_SettlementBenefit |
| Impairment Charge (Note 9) | 3,577us-gaap_ImpairmentOfIntangibleAssetsFinitelived | 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived | 0us-gaap_ImpairmentOfIntangibleAssetsFinitelived |
| Total operating expense | 22,007us-gaap_OperatingExpenses | 16,255us-gaap_OperatingExpenses | 15,350us-gaap_OperatingExpenses |
| Income (loss) from operations | (7,828)us-gaap_OperatingIncomeLoss | 416us-gaap_OperatingIncomeLoss | (1,098)us-gaap_OperatingIncomeLoss |
| Interest income | 4us-gaap_InterestAndOtherIncome | 2us-gaap_InterestAndOtherIncome | 7us-gaap_InterestAndOtherIncome |
| Interest expense | (10)us-gaap_InterestExpense | (13)us-gaap_InterestExpense | 0us-gaap_InterestExpense |
| Income (loss) from operations before taxes | (7,834)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | 405us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | (1,091)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest |
| Income tax (benefit) (Note 7) | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit |
| Net income (loss) | $ (7,834)us-gaap_NetIncomeLoss | $ 405us-gaap_NetIncomeLoss | $ (1,091)us-gaap_NetIncomeLoss |
| Basic income (loss) per share: | |||
| Net income (loss) (in dollars per share) | $ (0.47)us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | $ (0.07)us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare |
| Diluted income (loss) per share: | |||
| Net income (loss) (in dollars per share) | $ (0.47)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare | $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare | $ (0.07)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare |
| Weighted average common shares outstanding: | |||
| Basic (in shares) | 16,773us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 15,839us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 14,843us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| Diluted (in shares) | 16,773us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 16,276us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 14,843us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| X | ||||||||||
|
- Definition
Represents the amount of realized benefit as a consequence of a reduction of the previously recorded accrued royalties and commission obligation. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|